EGFR and cancer: DNA JB4 inhibits Src phosphorylation by direct binding to the SH3 domain of c-Src and suppresses invasion of cancer by disrupting the interaction between Src and Src-downstream targets such as EGFR, FAK, and STAT3 [162].